Mark Crockett, MDMolecular ImagingTargeted radiopharmaceuticals offer new hope for longer 'healthspans'Precision radiopharmaceuticals accurately target tumors while minimizing damage to healthy tissue, presenting an opportunity to extend not just lifespans but “healthspans,” Mark Crockett, MD, explains in this article.March 15, 2024Page 1 of 1Top StoriesMolecular ImagingChatGPT matches nuclear medicine experts on FDG-PET/CT scansModels excelled on cases with well-defined metabolic patterns, such as in typical cases of Alzheimer's disease, yet were less accurate on complex cases.CTHRCT bests chest x-ray when it comes to identifying ILDEconomicsCMS, FDA align with new breakthrough medical device coverage pathwayWomens ImagingWomen's Imaging MinnieCast, Episode 7: What to know about the ACP's breast cancer screening guidanceSponsor ContentTurning Innovation into Everyday Efficiency
